Insightful conversations with leading experts in the field of health care, medical research, policy, and more from the New England Journal of Medicine (NEJM). Each episode examines the many complexities found at the junction of medicine and society.
http://www.nejm.org/multimedia/audio-interview
Gesamtlänge aller Episoden: 8 days 30 minutes
NEJM Interview: Dr. Michele Friedner on how the concept of normality affects health care decisions.
Dr. Michele Friedner is an assistant professor in the Department of Comparative Human Development at the University of Chicago. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Friedner and Others. Embracing Multiple Normals — A 12-Year-Old Boy in India with a Cochlear Implant. N Engl J Med 2019;381:2381-2384.
NEJM Interview: Dr. Adewole Adamson on the role of machine learning in cancer diagnosis.
Dr. Adewole Adamson is a dermatologist and assistant professor in the Department of Internal Medicine at the University of Texas at Austin Dell Medical School. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. A.S. Adamson and H.G. Welch. Machine Learning and the Cancer-Diagnosis Problem — No Gold Standard. N Engl J Med 2019;381:2285-2287.
NEJM Interview: Dr. Goudarz Molaei on range expansion of the lone star tick and other tick species and implications for human health.
Goudarz Molaei is a research scientist at the Connecticut Agricultural Experiment Station and an associate clinical professor in the Department of Epidemiology of Microbial Diseases at the Yale School of Public Health. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. G. Molaei and Others. Bracing for the Worst — Range Expansion of the Lone Star Tick in the Northeastern United States. N Engl J Med 2019;381:2189-2192.
NEJM Interview: Dr. Peter J. Campbell on genome sequencing in cancer.
Dr. Peter Campbell is head of cancer, aging, and somatic mutation, senior group leader, and joint head of the Cancer Genome Project at the Wellcome Trust Sanger Institute and is a practicing hematologist at Addenbrooke’s Hospital in Cambridge, in the United Kingdom. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. J. Nangalia and P.J. Campbell. Genome Sequencing during a Patient’s Journey through Cancer. N Engl J Med 2019;381:2145-2156.
NEJM Interview: Dr. Jonathan Oberlander on legislation aimed at reducing spending on prescription drugs.
Dr. Jonathan Oberlander is a professor of social medicine and health policy and management at the University of North Carolina at Chapel Hill. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. S.B. Dusetzina and J. Oberlander. Advancing Legislation on Drug Pricing — Is There a Path Forward? N Engl J Med 2019;381:2081-2084. P.B. Bach. Which Drug Prices Should Medicare Negotiate? A “Too Little” or “Too Late” Approach. N Engl J Med 2019;381:2084-2086.
NEJM Interview: Dr. Ippolytos Kalofonos on the gatekeeper role played by U.S. physicians in facilitating vulnerable patients’ access to disability benefits.
Dr. Ippolytos Kalofonos is an assistant professor at the International Institute and Center for Social Medicine and Humanities at UCLA and the Greater Los Angeles Veterans Affairs Medical Center. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. I. Kalofonos. Biological Citizenship — A 53-Year-Old Man with Schizoaffective Disorder and PTSD Applying for Supplemental Security Income. N Engl J Med 2019;381:1985-1989.
NEJM Interview: Dr. Kevin De Cock on the research and public health benefits of autopsies and other forms of postmortem investigation.
Dr. Kevin De Cock is the Kenya country director of the Centers for Disease Control and Prevention. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. K.M. De Cock, E. Zielinski-Gutiérrez, and S.B. Lucas. Learning from the Dead. N Engl J Med 2019;381:1889-1891.
NEJM Interview: Dr. Michael Fralick on contributors — and proposed solutions — to high insulin prices in the United States.
Dr. Michael Fralick is an assistant professor in the Department of Medicine at the University of Toronto and a general internist at Mount Sinai Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. M. Fralick and A.S. Kesselheim. The U.S. Insulin Crisis — Rationing a Lifesaving Medication Discovered in the 1920s. N Engl J Med 2019;381:1793-1795.
NEJM Interview: Dr. Caleb Gardner on the limitations of an increasing focus on biologic knowledge in psychiatry.
Dr. Caleb Gardner is a psychiatrist who recently completed his residency at Cambridge Health Alliance. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. C. Gardner and A. Kleinman. Medicine and the Mind — The Consequences of Psychiatry’s Identity Crisis. N Engl J Med 2019;381:1697-1699.
NEJM Interview: Dr. Lakshmi Ganapathi on threats to medical deferred action.
Dr. Lakshmi Ganapathi is an attending physician in the Divisions of Infectious Diseases and Nephrology at Boston Children’s Hospital. Stephen Morrissey, the interviewer, is the Executive Managing Editor of the Journal. L. Ganapathi and Others. Medical Deferred Action — Living on Borrowed Time. N Engl J Med 2019;381:1601-1603.